Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Modern Strategy for Preclinical Pharmaceutical R&d: Towards the Virtual Research Company

Modern Strategy for Preclinical Pharmaceutical R&d: Towards the Virtual Research Company

Cavalla, David

Hardcover

Medical Reference

ISBN10: 0471971170
ISBN13: 9780471971177
Publisher: Wiley
Published: Oct 14 1997
Pages: 231
Weight: 1.10
Height: 0.75 Width: 6.04 Depth: 9.64
Language: English
The twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R&D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small biotechnology companies and research boutiques, and possibly even the virtual research company might play as contractors and collaborators.

Also from

Cavalla, David

View All

Also in

Medical Reference

View All